Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2013

Nov 8, 2013

34978_dirs_2013-11-08_1a59704d-ec33-4fd9-962b-36dd8fa3b39e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2013-11-05

Reporting Person: NAUMANN-ETIENNE RUEDIGER (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-05 Common Stock J 64019 Disposed 0 Indirect
2013-11-05 Common Stock A 9707 Acquired 9707 Direct
2013-11-05 Common Stock A 638 Acquired 638 Indirect

Footnotes

F1: Transactions reported on this form represent pro rata distributions, and not a purchase or sale, of securities by Intertec Healthcare Partners, to their respective general, limited partners, and members without consideration.

F2: The Reporting Person is a general partner of Intertec Healthcare Partners LP ("Intertec") and may be deemed to share voting and dispositive power of the shares held by Intertec. The Reporting Person disclaims beneficial ownership of the shares held by Intertec, except to the extent of his proportionate partnership interest therein.